Trial intelligence / Profile preview

HSK16149 for diabetic peripheral neuropathic pain

CTR20202015Phase 3Completed

Sponsor
Sichuan Haisco Pharmaceutical Co., Ltd.
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of crisugabalin besilate in diabetic polyneuropathy (DPN), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Oct 2020; status: completed.

02

Drugs

crisugabalin besilate
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on CTR20202015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20202015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call